The Impact of the COVID-19 on Pfizer: Past, Present and Future

Abstract

Towards the end of 2019, COVID-19 was discovered in Wuhan, Hubei Province, China, and rapidly spread worldwide, resulting in significant impact on the global economy. Despite the pandemic being a disaster for the world, it has also created business opportunities for some healthcare companies, with Pfizer being a prime example. During the COVID-19 pandemic, Pfizer and BioNTech jointly developed Comminate, a vaccine that has been instrumental in combating the infection and death crisis. At the same time, Pfizer also engaged in the development of effective drugs. However, Pfizer has also been exposed to some negative news, which has had a significant impact on its business performance and stock price. The impact of the pandemic on Pfizer can be reflected through the changes in Pfizer's operating performance before and after the pandemic. In the future, the ever-changing factors of the COVID-19 pandemic will continue to have a certain influence on Pfizer's future, and the company will need to develop new strategies to address future challenges in order to achieve long-term stable development.